Cargando…

Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis

BACKGROUND: Although rare, cytomegalovirus (CMV) reactivation can be lethal in patients with cancer. However, the criteria for the prevention of cytomegalovirus reactivation during cancer treatment are unclear. This study aimed to identify factors associated with CMV reactivation in patients with es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitagawa, Koichi, Okada, Hideaki, Miyazaki, Shuichiro, Funakoshi, Yohei, Sanada, Yukinari, Chayahara, Naoko, Mayahara, Hiroshi, Fujii, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559503/ https://www.ncbi.nlm.nih.gov/pubmed/34514723 http://dx.doi.org/10.1002/cam4.4269

Ejemplares similares

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports
por: Umemoto, Kumiko, et al.
Publicado: (2016)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design
por: Zheng, Yuyan, et al.
Publicado: (2021)

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
por: Kuwahara, Akiko, et al.
Publicado: (2009)

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
por: Mayahara, Hiroshi, et al.
Publicado: (2022)

Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
por: Zhang, Yang, et al.
Publicado: (2018)

Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
por: Takada, Akinori, et al.
Publicado: (2016)

Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis
por: Li, Jiaxin, et al.
Publicado: (2020)

Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
por: Wang, Qian, et al.
Publicado: (2021)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
por: Ikawa, Toshiki, et al.
Publicado: (2019)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
por: Dai, Honghai, et al.
Publicado: (2019)

The clinical outcomes of elderly esophageal cancer patients who received definitive chemoradiotherapy
por: Lu, Hao-Wei, et al.
Publicado: (2020)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy
por: White, Katherine L, et al.
Publicado: (2020)

A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study
por: Shoji, Hisanori, et al.
Publicado: (2015)

Cytomegalovirus-associated ulceration of gastric conduit after chemoradiotherapy following esophagectomy for cancer
por: Matsuda, Yasunori, et al.
Publicado: (2014)

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
por: Zhu, Shan, et al.
Publicado: (2016)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Cytomegalovirus‐associated esophagitis on early esophageal cancer in immunocompetent host: a case report
por: Murakami, Daisuke, et al.
Publicado: (2021)

Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer
por: Liang, Yao, et al.
Publicado: (2023)

Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities
por: Deng, Wei, et al.
Publicado: (2020)

Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma
por: Deng, Jiaying, et al.
Publicado: (2014)

Regarding human cytomegalovirus in neuroblastoma
por: Forslund, Ola, et al.
Publicado: (2014)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib
por: Lian, Xiangyao, et al.
Publicado: (2020)

Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
por: Song, Tao, et al.
Publicado: (2016)

Dietary carbohydrate intake and the risk of esophageal cancer: a meta-analysis
por: Xuan, Fei, et al.
Publicado: (2020)

TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells
por: Lan, Xinyan, et al.
Publicado: (2019)

The impact of a healthy lifestyle on the risk of esophageal and gastric cancer subtypes
por: van den Brandt, Piet A.
Publicado: (2022)

Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers
por: Huang, Chunyue, et al.
Publicado: (2019)

Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
por: Zhang, Peng, et al.
Publicado: (2014)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
por: Lo, Chien-Ming, et al.
Publicado: (2021)

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Xu, Ying-Ying, et al.
Publicado: (2021)

Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study
por: Takenaka, Kei, et al.
Publicado: (2015)

Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report
por: Sai, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oouu349kjqlbmntj9iqlpifbr3